SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-003271
Filing Date
2020-03-26
Accepted
2020-03-26 16:06:58
Documents
14
Period of Report
2020-03-26
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_032620.htm   iXBRL 8-K 36821
2 PRESS RELEASE ex99-1.htm EX-99.1 26328
6 GRAPHIC ex99-1_img001.jpg GRAPHIC 3942
  Complete submission text file 0001387131-20-003271.txt   260323

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20200326.xsd EX-101.SCH 3204
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20200326_lab.xml EX-101.LAB 35273
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20200326_pre.xml EX-101.PRE 23158
10 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_032620_htm.xml XML 3890
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 20746205
SIC: 2834 Pharmaceutical Preparations